2Bartley J. First case of VRSA identified in Michigan [ J ]. Infect Control Hosp Epidemiol,2002,23 (8) : 480.
3Wayne. Clinical and Laboratory Standards Institute. Performance standardsfor antimicrobial susceptibility testing: sixteenth informational supplement. CLSI document M100-S15 [ M ]. Pennsylvania:Nccls, 2006. 121 - 124.
4Arltaka N, Hanaki H, Cui L, et al. Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3,with heterogeneous resistance to vancomycin[ J]. Antimicrob Agents Chemother, 2001 ,45 (4) : 1292 - 1294.
5Inaba Y, Hiramatsu K. Rinsho N. Emergence of hetero-VRSA strains in Japanese hospitals and its countermeasure [ J ]. Nippon Rinsho,1998,56(10) : 2699 -2705.
6Hanaki H, Labischinski H, Inaba Y, et al. Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50 [ J]. J Antimicrob Chemother, 1998, 42(3):315 -320.
